M11.259 Other chondrocalcinosis, unspecified hip

Name of the Condition

• Other chondrocalcinosis, unspecified hip

Summary

Other chondrocalcinosis, unspecified hip refers to the deposition of calcium-containing crystals in the hip joint tissues, excluding calcium pyrophosphate dihydrate (CPPD) or hydroxyapatite. This condition causes joint inflammation, pain, and potential structural damage, often mimicking other arthritic diseases. Diagnosis typically requires identifying the specific crystal type through joint fluid analysis or tissue sampling.

Causes

Other chondrocalcinosis, unspecified hip is caused by the deposition of non-CPPD, non-hydroxyapatite calcium crystals (e.g., calcium oxalate, calcium phosphate) in the hip’s cartilage, synovium, or surrounding tissues. The exact triggers vary but may include metabolic imbalances, genetic factors, or underlying systemic conditions. Crystal formation provokes an inflammatory response, leading to joint symptoms.

Risk Factors

• Metabolic disorders (e.g., hyperoxaluria, hypophosphatasia).
• Chronic kidney disease or dialysis.
• Genetic predisposition to crystal formation.
• Exposure to certain medications or toxins.
• Hip trauma or surgery.

Symptoms

• Hip pain, swelling, and stiffness.
• Warmth and redness over the affected joint.
• Reduced range of motion.
• Recurrent episodes of inflammation.
• Systemic symptoms (e.g., fever) in severe cases.

Diagnosis

Diagnosis involves joint fluid analysis or tissue sampling to identify the specific crystal type, excluding CPPD or hydroxyapatite. Imaging (e.g., X-rays, MRI) may show calcifications, but crystal identification is definitive. Clinical evaluation assesses joint inflammation and rules out other arthritic conditions.

Treatment Options

Treatment focuses on reducing inflammation and managing pain. Nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids may alleviate symptoms. Underlying metabolic or systemic causes are addressed if identified. Physical therapy can help maintain joint function.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and severity. Early intervention may prevent joint damage, but chronic cases can lead to degenerative changes. Regular follow-up monitors symptoms and joint health, with adjustments to treatment as needed.

Complications

Potential complications include chronic joint pain, reduced mobility, and structural damage (e.g., cartilage loss). Severe inflammation may cause temporary disability. Untreated cases could progress to osteoarthritis-like changes.

Lifestyle & Prevention

Maintain a healthy weight to reduce hip stress. Manage underlying conditions (e.g., kidney disease) as directed. Avoid excessive joint strain, and follow medical advice for metabolic or genetic risk factors.

When to Seek Professional Help

Seek care if hip pain is severe, persistent, or worsening. Prompt evaluation is needed for sudden swelling, redness, or fever, which may indicate acute inflammation. Early diagnosis supports better outcomes.

Tips for Medical Coders

Use M11.259 for unspecified hip involvement. Document the absence of CPPD or hydroxyapatite crystal confirmation and specify the hip as the site. Include clinical details supporting the diagnosis, such as imaging or lab results, to ensure accurate coding.